Holiya

Holiya is an AI-powered women's healthtech company transforming how women living with chronic conditions are supported in the workplace.

We are building an intelligent healthcare platform that integrates evidence-based clinical protocols for the management of multiple, often overlapping chronic conditions with occupational health considerations. Holiya designs personalised, evolving health programmes for women living with gynaecological, digestive and autoimmune conditions, adapting to their individual health needs, symptoms, and specific work environments.

From night shifts and long-haul travel to physically demanding roles and prolonged desk-based work, Holiya recognises how different working environments can influence symptoms and the management of chronic conditions.

Through personalised, evolving healthcare programmes, Holiya helps women anticipate symptom flare-ups, proactively manage their conditions and adapt their care to the realities of their working lives, empowering them to better balance their health needs with professional demands.

For employers, Holiya offers a scalable, proactive approach to women's health, helping organisations improve female employee, retention and productivity while addressing the often-overlooked impact of presenteeism.

Holiya's MVP was developed with the support of an Innovate UK grant and has undergone extensive user research and early-stage testing, informed by insights from over 150 women. Initial testing has demonstrated strong market demand, with 91% of participants confirming an unmet need and an average user satisfaction score of 4.4/5.

Holiya is now part of the Daya Ventures Accelerator and was also selected for the Barclays Eagle Labs Female Founder Accelerator and the INCO–Visa Foundation CatalyseHer programme, recognising the potential of our approach to transforming women's health in the workplace.

Having successfully developed and tested our MVP, we are now entering our commercialisation phase, strengthening our clinical and technological capabilities, and preparing to launch our first corporate pilots to validate measurable improvements.